#5e2d92_SMALL_Nov-Dec 2024 DRA Journal Cover

From myth-busting photobiomodulation therapy to showcasing advanced aesthetic cases, this issue delivers practical insights for modern dental practice. Explore evidence-based techniques in implant and veneer rehabilitation, essential guidance on monkeypox protocols, and strategies for enhanced patient communication.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

Planmeca Launches Planmeca Viso® G3 CBCT

Planmeca, a leading manufacturer of dental equipment, has announced the expansion of its superior imaging line with the introduction of the Planmeca Viso® G3 for the North American market. This multifunctional Cone Beam Computed Tomography (CBCT) device is designed to meet all extraoral imaging needs, from 2D to 3D.

Comprehensive Imaging Capabilities

The Planmeca Viso® G3 completes Planmeca’s next-generation CBCT units, alongside the Planmeca Viso® G7 and Planmeca Viso® G5, all powered by the all-in-one Planmeca Romexis® dental software. With a Field of View (FOV) ranging from 3 x 3 to 20 x 10 cm, the Planmeca Viso® G3 offers high-quality 3D images of the full dentition, as well as the capability to capture detailed panoramic and bitewing images for comprehensive diagnosis.

Read: Planmeca Unveils Planmeca Viso G3 Imaging System at IDS 2023

Patient Safety and Comfort

Planmeca Viso® G3 prioritizes patient safety and comfort with advanced features. The Planmeca Ultra Low Dose™ protocol has been scientifically proven in nine studies to reduce the effective patient dose without compromising image quality. Additionally, the proprietary Planmeca CALM® algorithm for motion artifact correction can be applied both before and after acquisition, reducing the need for retakes and limiting radiation exposure.

“We are thrilled to offer this addition to our highly regarded Viso product line,” stated Glen Kendrick, Planmeca USA President. “With all the benefits of Planmeca Viso technology, the Viso G3 allows clinics desiring a 3D with fantastic usability and outstanding image quality to be introduced to the superiority of Planmeca CBCT imaging.”

Efficient and User-Friendly Workflow

The Planmeca Viso® G3 includes freely adjustable 3D volume size and anatomical target selection, ensuring a smooth and efficient imaging workflow. The user-friendly patient positioning programs, which include a live video view and virtual FOV adjustments, prioritize patient comfort.

Planmeca’s innovative product design assures that the Planmeca Viso® G3 can be upgraded to Planmeca Viso® G5 for a larger maximum 3D volume, securing a sustainable solution to grow with an expanding practice. Additionally, expanded treatment capability is available with the addition of the Planmeca ProCeph™ one-shot cephalostat.

About Planmeca USA

Planmeca USA is a subsidiary of Planmeca, the largest privately held company in the dental equipment market and one of the industry’s leading manufacturers of dental X-rays, CAD/CAM, and core equipment. With a North American office located in Charlotte, North Carolina, and international headquarters in Helsinki, Finland, Planmeca is well established in high-tech dental markets and currently serves 120 countries worldwide.

Read: Pearl and Planmeca Partner for AI-Powered Dentistry

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *